-
Ai T, Xu Y, Qiu L, Geraghty RJ, Chen L, 2015: Hydroxamic acids block replication of hepatitis C virus[J]. J Med Chem, 58, 785-800. doi: 10.1021/jm501330g
-
Aoki H, Hayashi J, Moriyama M, Arakawa Y, Hino O, 2000: Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1[J]. J Virol, 74, 1736-1741. doi: 10.1128/JVI.74.4.1736-1741.2000
-
Berthiaume M, Boufaied N, Moisan A, Gaudreau L, 2006: High levels of oxidative stress globally inhibit gene transcription and histone acetylation[J]. DNA Cell Biol, 25, 124-134. doi: 10.1089/dna.2006.25.124
-
Bird A, 2007: Perceptions of epigenetics[J]. Nature, 447, 396-398. doi: 10.1038/nature05913
-
Bugianesi E, Salamone F, Negro F, 2012: The interaction of metabolic factors with HCV infection: does it matter?[J]. J Hepatol, 56, S56-S65.
-
Chen J, Zhao Y, Zhang C, Chen H, Feng J, Chi X, Pan Y, Du J, Guo M, Cao H, Wang Z, Pei R, Wang Q, Pan L, Niu J, Chen X, Tang H, 2014: Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice[J]. Cell Res, 24, 1050-1066. doi: 10.1038/cr.2014.116
-
Chen J, Wang N, Dong M, Guo M, Zhao Y, Zhuo Z, Zhang C, Chi X, Pan Y, Jiang J, Tang H, Niu J, Yang D, Li Z, Han X, Wang Q, Chen X, 2015: The metabolic regulator histone deacetylase 9 contributes to glucose homeostasis abnormality induced by hepatitis C virus infection[J]. Diabetes, 64, 4088-4098. doi: 10.2337/db15-0197
-
Gottwein JM, Pham LV, Mikkelsen LS, Ghanem L, Ramirez S, Scheel TKH, Carlsen THR, Bukh J, 2018: Efficacy of NS5A inhibitors against hepatitis C virus genotypes 1-7 and escape variants[J]. Gastroenterology, 154, 1435-1448. doi: 10.1053/j.gastro.2017.12.015
-
Guo M, Pei R, Yang Q, Cao H, Wang Y, Wu C, Chen J, Zhou Y, Hu X, Lu M, Chen X, 2015: Phosphatidylserine-specific phospholipase A1 involved in hepatitis C virus assembly through NS2 complex formation[J]. J Virol, 89, 2367-2377. doi: 10.1128/JVI.02982-14
-
Heo YA, Deeks ED, 2018: Sofosbuvir/velpatasvir/voxilaprevir: a review in chronic hepatitis C[J]. Drugs, 78, 577-587. doi: 10.1007/s40265-018-0895-5
-
Ivanov AV, Smirnova OA, Ivanova ON, Masalova OV, Kochetkov SN, Isaguliants MG, 2011: Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells[J]. PLoS ONE, 6, e24957-. doi: 10.1371/journal.pone.0024957
-
Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P, 2005: Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA[J]. Science, 309, 1577-1581. doi: 10.1126/science.1113329
-
Kato J, Kobune M, Nakamura T, Kuroiwa G, Takada K, Takimoto R, Sato Y, Fujikawa K, Takahashi M, Takayama T, Ikeda T, Niitsu Y, 2001: Normalization of elevated hepatic 8-hydroxy-2′-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet[J]. Cancer Res, 61, 8697-8702.
-
Kawamura Y, Akuta N, Sezaki H, Hosaka T, Someya T, Kobayashi M, Suzuki F, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kumada H, 2005: Determinants of serum ALT normalization after phlebotomy in patients with chronic hepatitis C infection[J]. J Gastroenterol, 40, 901-906. doi: 10.1007/s00535-005-1636-6
-
Ke Q, Costa M, 2006: Hypoxia-inducible factor-1 (HIF-1)[J]. Mol Pharmacol, 70, 1469-1480. doi: 10.1124/mol.106.027029
-
Lu YS, Kashida Y, Kulp SK, Wang YC, Wang D, Hung JH, Tang M, Lin ZZ, Chen TJ, Cheng AL, Chen CS, 2007: Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma[J]. Hepatology, 46, 1119-1130.
-
Lyberopoulou A, Chachami G, Gatselis NK, Kyratzopoulou E, Saitis A, Gabeta S, Eliades P, Paraskeva E, Zachou K, Koukoulis GK, Mamalaki A, Dalekos GN, Simos G, 2015: Low serum hepcidin in patients with autoimmune liver diseases[J]. PLoS ONE, 10, e0135486-. doi: 10.1371/journal.pone.0135486
-
Mancone C, Steindler C, Santangelo L, Simonte G, Vlassi C, Longo MA, D'Offizi G, Di Giacomo C, Pucillo LP, Amicone L, Tripodi M, Alonzi T, 2011: Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins[J]. Gut, 60, 378-386. doi: 10.1136/gut.2010.211292
-
Mifuji R, Kobayashi Y, Ma N, Qiang QL, Urawa N, Horiike S, Iwasa M, Kaito M, Malavasi F, Adachi Y, 2006: Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C[J]. J Gastroenterol Hepatol, 21, 144-151. doi: 10.1111/jgh.2006.21.issue-1
-
Minichini C, Starace M, De Pascalis S, Macera M, Occhiello L, Caroprese M, Vitrone M, Iovinella V, Guerrera B, Masarone M, Coppola N (2018) HCV-genotype 3 h, a difficult-to-diagnose sub-genotype in the DAA era. Antivir Ther. https://doi.org/10.3851/IMP3228
-
Miura K, Taura K, Kodama Y, Schnabl B, Brenner DA, 2008: Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity[J]. Hepatology, 48, 1420-1429. doi: 10.1002/hep.22486
-
Nishina S, Hino K, Korenaga M, Vecchi C, Pietrangelo A, Mizukami Y, Furutani T, Sakai A, Okuda M, Hidaka I, Okita K, Sakaida I, 2008: Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription[J]. Gastroenterology, 134, 226-238. doi: 10.1053/j.gastro.2007.10.011
-
Peyssonnaux C, Zinkernagel AS, Schuepbach RA, Rankin E, Vaulont S, Haase VH, Nizet V, Johnson RS, 2007: Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)[J]. J Clin Invest, 117, 1926-1932. doi: 10.1172/JCI31370
-
Pietrangelo A, Dierssen U, Valli L, Garuti C, Rump A, Corradini E, Ernst M, Klein C, Trautwein C, 2007: STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo[J]. Gastroenterology, 132, 294-300. doi: 10.1053/j.gastro.2006.10.018
-
Puoti M, Foster GR, Wang S, Mutimer D, Gane E, Moreno C, Chang TT, Lee SS, Marinho R, DuFour JF, Pol S, Hezode C, Gordon SC, Strasser SI, Thuluvath PJ, Zhang Z, Lovell S, Pilot-Matias T, Mensa FJ (2018) High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir: integrated analysis of HCV genotype 1-6 patients without cirrhosis. J Hepatol. https://doi.org/10.1016/j.jhep.2018.03.007
-
Sato A, Saito Y, Sugiyama K, Sakasegawa N, Muramatsu T, Fukuda S, Yoneya M, Kimura M, Ebinuma H, Hibi T, Ikeda M, Kato N, Saito H, 2013: Suppressive effect of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) on hepatitis C virus replication[J]. J Cell Biochem, 114, 1987-1996. doi: 10.1002/jcb.24541
-
Schumacker PT, 2005: Hypoxia-inducible factor-1 (HIF-1)[J]. Crit Care Med, 33, S423-S425. doi: 10.1097/01.CCM.0000191716.38566.E0
-
Sengupta N, Seto E, 2004: Regulation of histone deacetylase activities[J]. J Cell Biochem, 93, 57-67. doi: 10.1002/(ISSN)1097-4644
-
Shu XS, Li L, Tao Q, 2012: Chromatin regulators with tumor suppressor properties and their alterations in human cancers[J]. Epigenomics, 4, 537-549. doi: 10.2217/epi.12.50
-
Su X, Liu S, Zhang X, Lam SM, Hu X, Zhou Y, Chen J, Wang Y, Wu C, Shui G, Lu M, Pei R, Chen X, 2017: Requirement of cytosolic phospholipase A2 gamma in lipid droplet formation[J]. Biochim Biophys Acta, 1862, 692-705. doi: 10.1016/j.bbalip.2017.03.007
-
Sun Z, Miller RA, Patel RT, Chen J, Dhir R, Wang H, Zhang D, Graham MJ, Unterman TG, Shulman GI, Sztalryd C, Bennett MJ, Ahima RS, Birnbaum MJ, Lazar MA, 2012: Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration[J]. Nat Med, 18, 934-942. doi: 10.1038/nm.2744
-
Tovar-Castillo LE, Cancino-Diaz JC, Garcia-Vazquez F, Cancino-Gomez FG, Leon-Dorantes G, Blancas-Gonzalez F, Jimenez-Zamudio L, Garcia-Latorre E, Cancino-Diaz ME, 2007: Under-expression of VHL and over-expression of HDAC-1, HIF-1alpha, LL-37, and IAP-2 in affected skin biopsies of patients with psoriasis[J]. Int J Dermatol, 46, 239-246. doi: 10.1111/ijd.2007.46.issue-3
-
Vaillancourt FH, Brault M, Pilote L, Uyttersprot N, Gaillard ET, Stoltz JH, Knight BL, Pantages L, McFarland M, Breitfelder S, Chiu TT, Mahrouche L, Faucher AM, Cartier M, Cordingley MG, Bethell RC, Jiang H, White PW, Kukolj G, 2012: Evaluation of phosphatidylinositol-4-kinase IIIalpha as a hepatitis C virus drug target[J]. J Virol, 86, 11595-11607. doi: 10.1128/JVI.01320-12
-
Vassilaki N, Kalliampakou KI, Kotta-Loizou I, Befani C, Liakos P, Simos G, Mentis AF, Kalliaropoulos A, Doumba PP, Smirlis D, Foka P, Bauhofer O, Poenisch M, Windisch MP, Lee ME, Koskinas J, Bartenschlager R, Mavromara P, 2013: Low oxygen tension enhances hepatitis C virus replication[J]. J Virol, 87, 2935-2948. doi: 10.1128/JVI.02534-12
-
Vecchi C, Montosi G, Zhang K, Lamberti I, Duncan SA, Kaufman RJ, Pietrangelo A, 2009: ER stress controls iron metabolism through induction of hepcidin[J]. Science, 325, 877-880. doi: 10.1126/science.1176639
-
World Health Organization Fact sheet, Updated October 2017
-
Xu S, Pei R, Guo M, Han Q, Lai J, Wang Y, Wu C, Zhou Y, Lu M, Chen X, 2012: Cytosolic phospholipase A2 gamma is involved in hepatitis C virus replication and assembly[J]. J Virol, 86, 13025-13037. doi: 10.1128/JVI.01785-12
-
Yang XJ, Gregoire S, 2005: Class Ⅱ histone deacetylases: from sequence to function, regulation, and clinical implication[J]. Mol Cell Biol, 25, 2873-2884. doi: 10.1128/MCB.25.8.2873-2884.2005
-
Yuan ZL, Guan YJ, Chatterjee D, Chin YE, 2005: Stat3 dimerization regulated by reversible acetylation of a single lysine residue[J]. Science, 307, 269-273. doi: 10.1126/science.1105166
-
Zhai N, Li H, Song H, Yang Y, Cui A, Li T, Niu J, Crispe IN, Su L, Tu Z, 2017: Hepatitis C virus induces MDSCs-like monocytes through TLR2/PI3K/AKT/STAT3 signaling[J]. PLoS ONE, 12, e0170516-. doi: 10.1371/journal.pone.0170516